Yuca, Sevil AriRendtorff, Nanna DahlBoulahbel, HoudaLodahl, MarianneTranebjaerg, LisbethCesur, YAŞARDogan, MuratYilmaz, CahideAkgun, CihangirAcikgoz, Mehmet2020-10-292020-10-292012-01-01Yuca S. A. , Rendtorff N. D. , Boulahbel H., Lodahl M., Tranebjaerg L., Cesur Y., Dogan M., Yilmaz C., Akgun C., Acikgoz M., -Rapidly progressive renal disease as part of Wolfram syndrome in a large inbred Turkish family due to a novel WFS1 mutation (p.Leu511Pro)-, EUROPEAN JOURNAL OF MEDICAL GENETICS, cilt.55, ss.37-42, 2012http://hdl.handle.net/20.500.12645/26427Wolfram syndrome, also named -DIDMOAD- (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness), is an inherited association of juvenile-onset diabetes mellitus and optic atrophy as key diagnostic criteria. Renal tract abnormalities and neurodegenerative disorder may occur in the third and fourth decade. The wolframin gene, WFS1, associated with this syndrome, is located on chromosome 4p16.1. Many mutations have been described since the identification of WFS1 as the cause of Wolfram syndrome. We identified a new homozygous WFS1 mutation (c. 1532T>C; p.Leu511Pro) causing Wolfram syndrome in a large inbred Turkish family. The patients showed early onset of IDDM, diabetes insipidus, optic atrophy, sensorineural hearing impairment and very rapid progression to renal failure before age 12 in three females. Ectopic expression of the wolframin mutant in HEK cells results in greatly reduced levels of protein expression compared to wild-type wolframin, strongly supporting that this mutation is disease-causing. The mutation showed perfect segregation with disease in the family, characterized by early and severe clinical manifestations. (C) 2011 Elsevier Masson SAS. All rights reserved.ArticleWOS:0003075390000088485719012610.1016/j.ejmg.2011.08.005